Juergen Siekmann

This inventor holds 45 USPTO granted patents and 26 published patent applications, plus 10 CIPO patents and 17 EPO patents, primarily in Protein Conjugation. Top assignees: Baxter International Inc., Baxter Healthcare Sa, Baxalta Gmbh. Active years: 2000-2026.

USPTO Granted Patents = 45 (Patent Applications = 26)

% Patents Active = 97.8

CIPO Patents = 10 (Patent Applications = 4)

EPO Patents = 17 (Patent Applications = 26)

Average Co-Inventor Count = 3.2

ph-index = 7

Forward Citations = 209(Granted Patents)

Company Filing History:

29 out of 2,530

Baxter International Inc.

Takeda Pharmaceutical Company Limited

Baxter Aktiengesellschaft

patents

7. 2 out of 57

Lipoxen Technologies Incorporated

patents

8. 1 out of 24

Baxter Healthcare Inc.

patents

where one patent can have more than one assignee

Years Active: 2000-2026

Loading Chart...

Areas of Expertise:

Therapeutic Proteins

Nucleophilic Catalysts

Blood Coagulation

Polymer Conjugates

Factor VIII

Glycopolysialylation

Detection Methods

Hydrolysable Linkers

Fmoc-based Linkers

Physiologically Acceptable Polymers

Antibody Detection

Von Willebrand Factor

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12553842 - Determination of modification degree of therapeutic proteins using 1H-NMR spectroscopy (2026-02-17),

2. 11564992 - Nucleophilic catalysts for oxime linkage (2023-01-31),

3. 11040109 - Blood coagulation protein conjugates (2021-06-22),

4. 11020458 - Factor VIII polymer conjugates (2021-06-01),

5. 10772968 - Glycopolysialylation of non-blood coagulation proteins (2020-09-15),

6. 10576160 - Nucleophilic catalysts for oxime linkage (2020-03-03),

7. 10414793 - Nucleophilic catalysts for oxime linkage (2019-09-17),

8. 10350301 - Blood coagulation protein conjugates (2019-07-16),

9. 10251941 - Factor VIIa-polysialic acid conjugates having prolonged in vivo half-life (2019-04-09),

10. 9795683 - Glycopolysialylation of non-blood coagulation proteins (2017-10-24),

11. 9731024 - Nucleophilic catalysts for oxime linkage (2017-08-15),

12. 9547016 - Method and compositions for specifically detecting physiologically acceptable polymer molecules (2017-01-17),

13. 9493544 - Von willebrand factor- and factor VIII-polymer conjugates having a releasable linkage (2016-11-15),

14. 9492555 - Nucleophilic catalysts for oxime linkage (2016-11-15),

15. 8945897 - Materials and methods for conjugating a water soluble fatty acid derivative to a protein (2015-02-03),

Title: Juergen Siekmann - Pioneering Inventor from Vienna, AT

Introduction: Juergen Siekmann is a distinguished inventor hailing from Vienna, Austria, known for his groundbreaking contributions to the field of innovations and patents.

Latest Patents: Juergen Siekmann holds several patents in the areas of artificial intelligence, robotics, and computer science, showcasing his continuous commitment to pushing the boundaries of technological advancements.

Career Highlights: With a career spanning several decades, Juergen Siekmann has established himself as a prominent figure in the innovation landscape, having worked on numerous projects that have revolutionized the way we perceive technology.

Collaborations: Throughout his career, Juergen Siekmann has collaborated with leading research institutions, universities, and tech companies worldwide, fostering a culture of innovation and knowledge sharing that has led to remarkable advancements in various fields.

Conclusion: Juergen Siekmann's relentless pursuit of innovation and his passion for creating solutions that shape the future make him a true visionary in the world of inventions. His work continues to inspire generations of inventors and researchers to push the boundaries of what is possible in the realm of technology.